Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 45 entries
Sorted by: Best Match Show Resources per page
The status of Eustachian tube balloon dilations in Nordic countries.

World journal of otorhinolaryngology - head and neck surgery

Silvola JT, Sinkkonen ST, Wanscher J, Westman E, Holm NH, Ovesen T.
PMID: 31750427
World J Otorhinolaryngol Head Neck Surg. 2019 Oct 19;5(3):148-151. doi: 10.1016/j.wjorl.2019.09.002. eCollection 2019 Sep.

There is no unanimous consensus for indications of eustachian tube balloon dilation (ETBD). Nordic countries have relatively similar hospital organizations and treatment guidelines. Therefore, it was logical to organize a consensus meeting of ETBD. The symposium: Nordic Experiences on...

Cite
Silvola JT, Sinkkonen ST, Wanscher J, et al. The status of Eustachian tube balloon dilations in Nordic countries. World J Otorhinolaryngol Head Neck Surg. 2019;5(3):148-151doi: 10.1016/j.wjorl.2019.09.002.
Silvola, J. T., Sinkkonen, S. T., Wanscher, J., Westman, E., Holm, N. H., & Ovesen, T. (2019). The status of Eustachian tube balloon dilations in Nordic countries. World journal of otorhinolaryngology - head and neck surgery, 5(3), 148-151. https://doi.org/10.1016/j.wjorl.2019.09.002
Silvola, Juha T, et al. "The status of Eustachian tube balloon dilations in Nordic countries." World journal of otorhinolaryngology - head and neck surgery vol. 5,3 (2019): 148-151. doi: https://doi.org/10.1016/j.wjorl.2019.09.002
Silvola JT, Sinkkonen ST, Wanscher J, Westman E, Holm NH, Ovesen T. The status of Eustachian tube balloon dilations in Nordic countries. World J Otorhinolaryngol Head Neck Surg. 2019 Oct 19;5(3):148-151. doi: 10.1016/j.wjorl.2019.09.002. eCollection 2019 Sep. PMID: 31750427; PMCID: PMC6849347.
Copy Download .nbib Format: NLM
Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes.

Therapeutics and clinical risk management

Schernthaner G, Jarvis S, Lotan C, Prázný M, Wanner C, Wascher TC.
PMID: 28144148
Ther Clin Risk Manag. 2017 Jan 13;13:69-79. doi: 10.2147/TCRM.S121804. eCollection 2017.

Diabetes is a global health emergency projected to affect 642 million people by 2040. Type 2 diabetes (T2D) represents 90% of diabetes cases and is associated with a range of cardiovascular (CV) risk factors that are more than double...

Cite
Schernthaner G, Jarvis S, Lotan C, et al. Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes. Ther Clin Risk Manag. 2017;13:69-79doi: 10.2147/TCRM.S121804.
Schernthaner, G., Jarvis, S., Lotan, C., Prázný, M., Wanner, C., & Wascher, T. C. (2017). Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes. Therapeutics and clinical risk management, 1369-79. https://doi.org/10.2147/TCRM.S121804
Schernthaner, Guntram, et al. "Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes." Therapeutics and clinical risk management vol. 13 (2017): 69-79. doi: https://doi.org/10.2147/TCRM.S121804
Schernthaner G, Jarvis S, Lotan C, Prázný M, Wanner C, Wascher TC. Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes. Ther Clin Risk Manag. 2017 Jan 13;13:69-79. doi: 10.2147/TCRM.S121804. eCollection 2017. PMID: 28144148; PMCID: PMC5245806.
Copy Download .nbib Format: NLM
Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparation.

Translational lung cancer research

Kong FS, Zhao L, Wang L, Chen Y, Hu J, Fu X, Bai C, Wang L, Lawrence TS, Anscher MS, Dicker A, Okunieff P.
PMID: 29218266
Transl Lung Cancer Res. 2017 Dec;6(6):625-634. doi: 10.21037/tlcr.2017.09.13.

BACKGROUND: Sample quality is critical for biomarker detection in oncology, and platelet degradation and contamination in plasma have a remarkable impact on the ability to accurately quantify many blood-based biomarkers. Platelet factor 4 (PF4) can be used as an...

Cite
Kong FS, Zhao L, Wang L, et al. Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparation. Transl Lung Cancer Res. 2017;6(6):625-634doi: 10.21037/tlcr.2017.09.13.
Kong, F. S., Zhao, L., Wang, L., Chen, Y., Hu, J., Fu, X., Bai, C., Wang, L., Lawrence, T. S., Anscher, M. S., Dicker, A., & Okunieff, P. (2017). Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparation. Translational lung cancer research, 6(6), 625-634. https://doi.org/10.21037/tlcr.2017.09.13
Kong, Feng-Ming Spring, et al. "Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparation." Translational lung cancer research vol. 6,6 (2017): 625-634. doi: https://doi.org/10.21037/tlcr.2017.09.13
Kong FS, Zhao L, Wang L, Chen Y, Hu J, Fu X, Bai C, Wang L, Lawrence TS, Anscher MS, Dicker A, Okunieff P. Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparation. Transl Lung Cancer Res. 2017 Dec;6(6):625-634. doi: 10.21037/tlcr.2017.09.13. PMID: 29218266; PMCID: PMC5709139.
Copy Download .nbib Format: NLM
Preoperative radiotherapy for muscle-invading bladder-carcinoma.

International journal of oncology

Cox J, Greven K, Anscher M, Morgan T.
PMID: 21584580
Int J Oncol. 1992 Oct;1(5):555-60. doi: 10.3892/ijo.1.5.555.

One hundred five patients with clinical stage T2-T4 transitional cell bladder carcinoma who completed either low-dose (20-26 Gy) or high dose (40-50 Gy) preoperative radiotherapy (RT) followed by cystectomy were reviewed. Five-year actuarial survival was 42%, 52%, and 17%...

Cite
Cox J, Greven K, Anscher M, et al. Preoperative radiotherapy for muscle-invading bladder-carcinoma. Int J Oncol. 1992;1(5):555-60doi: 10.3892/ijo.1.5.555.
Cox, J., Greven, K., Anscher, M., & Morgan, T. (1992). Preoperative radiotherapy for muscle-invading bladder-carcinoma. International journal of oncology, 1(5), 555-60. https://doi.org/10.3892/ijo.1.5.555
Cox, J, et al. "Preoperative radiotherapy for muscle-invading bladder-carcinoma." International journal of oncology vol. 1,5 (1992): 555-60. doi: https://doi.org/10.3892/ijo.1.5.555
Cox J, Greven K, Anscher M, Morgan T. Preoperative radiotherapy for muscle-invading bladder-carcinoma. Int J Oncol. 1992 Oct;1(5):555-60. doi: 10.3892/ijo.1.5.555. PMID: 21584580.
Copy Download .nbib Format: NLM
The lack of impact of treatment time on the outcome of definitive radiotherapy for carcinoma of the prostate.

International journal of oncology

Anscher M, Montana G, Dodge R, Gaydica E, Dewhirst M, Prosnitz L.
PMID: 21573422
Int J Oncol. 1993 Oct;3(4):707-11. doi: 10.3892/ijo.3.4.707.

The records of 180 patients definitively irradiated for newly diagnosed adenocarcinoma of the prostate between 1970 and 1988 at Duke University Medical Center (107 patients from 1970-1983) and Moore Regional Hospital (73 patients from 1981-1988) were reviewed to determine...

Cite
Anscher M, Montana G, Dodge R, et al. The lack of impact of treatment time on the outcome of definitive radiotherapy for carcinoma of the prostate. Int J Oncol. 1993;3(4):707-11doi: 10.3892/ijo.3.4.707.
Anscher, M., Montana, G., Dodge, R., Gaydica, E., Dewhirst, M., & Prosnitz, L. (1993). The lack of impact of treatment time on the outcome of definitive radiotherapy for carcinoma of the prostate. International journal of oncology, 3(4), 707-11. https://doi.org/10.3892/ijo.3.4.707
Anscher, M, et al. "The lack of impact of treatment time on the outcome of definitive radiotherapy for carcinoma of the prostate." International journal of oncology vol. 3,4 (1993): 707-11. doi: https://doi.org/10.3892/ijo.3.4.707
Anscher M, Montana G, Dodge R, Gaydica E, Dewhirst M, Prosnitz L. The lack of impact of treatment time on the outcome of definitive radiotherapy for carcinoma of the prostate. Int J Oncol. 1993 Oct;3(4):707-11. doi: 10.3892/ijo.3.4.707. PMID: 21573422.
Copy Download .nbib Format: NLM
Low level of procoagulant platelet microparticles is associated with impaired coagulation and transfusion requirements in trauma patients.

The journal of trauma and acute care surgery

Windeløv NA, Johansson PI, Sørensen AM, Perner A, Wanscher M, Larsen CF, Ostrowski SR, Rasmussen LS.
PMID: 25494419
J Trauma Acute Care Surg. 2014 Nov;77(5):692-700. doi: 10.1097/TA.0000000000000437.

BACKGROUND: Following activation, platelets release small vesicles called platelet-derived microparticles (PMPs). PMPs accelerate thrombin generation and thus clot formation at sites of injury by exposing the procoagulant membrane phospholipid phosphatidylserine (PS). The role of PMPs in coagulopathy and hemorrhage...

Cite
Windeløv NA, Johansson PI, Sørensen AM, et al. Low level of procoagulant platelet microparticles is associated with impaired coagulation and transfusion requirements in trauma patients. J Trauma Acute Care Surg. 2014;77(5):692-700doi: 10.1097/TA.0000000000000437.
Windeløv, N. A., Johansson, P. I., Sørensen, A. M., Perner, A., Wanscher, M., Larsen, C. F., Ostrowski, S. R., & Rasmussen, L. S. (2014). Low level of procoagulant platelet microparticles is associated with impaired coagulation and transfusion requirements in trauma patients. The journal of trauma and acute care surgery, 77(5), 692-700. https://doi.org/10.1097/TA.0000000000000437
Windeløv, Nis Agerlin, et al. "Low level of procoagulant platelet microparticles is associated with impaired coagulation and transfusion requirements in trauma patients." The journal of trauma and acute care surgery vol. 77,5 (2014): 692-700. doi: https://doi.org/10.1097/TA.0000000000000437
Windeløv NA, Johansson PI, Sørensen AM, Perner A, Wanscher M, Larsen CF, Ostrowski SR, Rasmussen LS. Low level of procoagulant platelet microparticles is associated with impaired coagulation and transfusion requirements in trauma patients. J Trauma Acute Care Surg. 2014 Nov;77(5):692-700. doi: 10.1097/TA.0000000000000437. PMID: 25494419.
Copy Download .nbib Format: NLM
Microbiology of pozol, a Mexican fermented maize dough.

World journal of microbiology & biotechnology

Nuraida L, Wacher MC, Owens JD.
PMID: 24414915
World J Microbiol Biotechnol. 1995 Sep;11(5):567-71. doi: 10.1007/BF00286375.

Mexican fermented maize dough, pozol, including traditional banana leaf-wrapped samples and material in plastic bags, was purchased. All samples were pH 4.7 to 5.7 approx. 12 h after preparation, pH declining to 3.6 to 3.9 after 6 to 9...

Cite
Nuraida L, Wacher MC, Owens JD. Microbiology of pozol, a Mexican fermented maize dough. World J Microbiol Biotechnol. 1995;11(5):567-71doi: 10.1007/BF00286375.
Nuraida, L., Wacher, M. C., & Owens, J. D. (1995). Microbiology of pozol, a Mexican fermented maize dough. World journal of microbiology & biotechnology, 11(5), 567-71. https://doi.org/10.1007/BF00286375
Nuraida, L, et al. "Microbiology of pozol, a Mexican fermented maize dough." World journal of microbiology & biotechnology vol. 11,5 (1995): 567-71. doi: https://doi.org/10.1007/BF00286375
Nuraida L, Wacher MC, Owens JD. Microbiology of pozol, a Mexican fermented maize dough. World J Microbiol Biotechnol. 1995 Sep;11(5):567-71. doi: 10.1007/BF00286375. PMID: 24414915.
Copy Download .nbib Format: NLM
Performance of complex snow cover descriptions in a distributed hydrological model system: A case study for the high Alpine terrain of the Berchtesgaden Alps.

Water resources research

Warscher M, Strasser U, Kraller G, Marke T, Franz H, Kunstmann H.
PMID: 24223443
Water Resour Res. 2013 May;49(5):2619-2637. doi: 10.1002/wrcr.20219. Epub 2013 May 28.

[1] Runoff generation in Alpine regions is typically affected by snow processes. Snow accumulation, storage, redistribution, and ablation control the availability of water. In this study, several robust parameterizations describing snow processes in Alpine environments were implemented in a...

Cite
Warscher M, Strasser U, Kraller G, et al. Performance of complex snow cover descriptions in a distributed hydrological model system: A case study for the high Alpine terrain of the Berchtesgaden Alps. Water Resour Res. 2013;49(5):2619-2637doi: 10.1002/wrcr.20219.
Warscher, M., Strasser, U., Kraller, G., Marke, T., Franz, H., & Kunstmann, H. (2013). Performance of complex snow cover descriptions in a distributed hydrological model system: A case study for the high Alpine terrain of the Berchtesgaden Alps. Water resources research, 49(5), 2619-2637. https://doi.org/10.1002/wrcr.20219
Warscher, M, et al. "Performance of complex snow cover descriptions in a distributed hydrological model system: A case study for the high Alpine terrain of the Berchtesgaden Alps." Water resources research vol. 49,5 (2013): 2619-2637. doi: https://doi.org/10.1002/wrcr.20219
Warscher M, Strasser U, Kraller G, Marke T, Franz H, Kunstmann H. Performance of complex snow cover descriptions in a distributed hydrological model system: A case study for the high Alpine terrain of the Berchtesgaden Alps. Water Resour Res. 2013 May;49(5):2619-2637. doi: 10.1002/wrcr.20219. Epub 2013 May 28. PMID: 24223443; PMCID: PMC3813985.
Copy Download .nbib Format: NLM
Corrigendum to "Highly malignant routine EEG predicts poor prognosis after cardiac arrest in the Target Temperature Management trial" [Resuscitation 131 (2019) 24-28].

Resuscitation

Backman S, Cronberg T, Friberg H, Ullén S, Horn J, Kjaergaard J, Hassager C, Wanscher M, Nielsen N, Westhall E.
PMID: 31726401
Resuscitation. 2019 Dec;145:82. doi: 10.1016/j.resuscitation.2019.10.023. Epub 2019 Nov 11.

No abstract available.

Cite
Backman S, Cronberg T, Friberg H, et al. Corrigendum to "Highly malignant routine EEG predicts poor prognosis after cardiac arrest in the Target Temperature Management trial" [Resuscitation 131 (2019) 24-28]. Resuscitation. 2019;145:82doi: 10.1016/j.resuscitation.2019.10.023.
Backman, S., Cronberg, T., Friberg, H., Ullén, S., Horn, J., Kjaergaard, J., Hassager, C., Wanscher, M., Nielsen, N., & Westhall, E. (2019). Corrigendum to "Highly malignant routine EEG predicts poor prognosis after cardiac arrest in the Target Temperature Management trial" [Resuscitation 131 (2019) 24-28]. Resuscitation, 14582. https://doi.org/10.1016/j.resuscitation.2019.10.023
Backman, S, et al. "Corrigendum to "Highly malignant routine EEG predicts poor prognosis after cardiac arrest in the Target Temperature Management trial" [Resuscitation 131 (2019) 24-28]." Resuscitation vol. 145 (2019): 82. doi: https://doi.org/10.1016/j.resuscitation.2019.10.023
Backman S, Cronberg T, Friberg H, Ullén S, Horn J, Kjaergaard J, Hassager C, Wanscher M, Nielsen N, Westhall E. Corrigendum to "Highly malignant routine EEG predicts poor prognosis after cardiac arrest in the Target Temperature Management trial" [Resuscitation 131 (2019) 24-28]. Resuscitation. 2019 Dec;145:82. doi: 10.1016/j.resuscitation.2019.10.023. Epub 2019 Nov 11. PMID: 31726401.
Copy Download .nbib Format: NLM
State of Privileging in Pharmacy: A Survey of Vizient-Affiliated Institutions.

Hospital pharmacy

Richards J, Wascher M, Alwan M, Beardsley J, Naseman R, Nesbit T, Trujillo T, Fuller P.
PMID: 31762483
Hosp Pharm. 2019 Dec;54(6):365-370. doi: 10.1177/0018578718802831. Epub 2018 Sep 22.

No abstract available.

Cite
Richards J, Wascher M, Alwan M, et al. State of Privileging in Pharmacy: A Survey of Vizient-Affiliated Institutions. Hosp Pharm. 2018;54(6):365-370doi: 10.1177/0018578718802831.
Richards, J., Wascher, M., Alwan, M., Beardsley, J., Naseman, R., Nesbit, T., Trujillo, T., & Fuller, P. (2019). State of Privileging in Pharmacy: A Survey of Vizient-Affiliated Institutions. Hospital pharmacy, 54(6), 365-370. https://doi.org/10.1177/0018578718802831
Richards, Jessika, et al. "State of Privileging in Pharmacy: A Survey of Vizient-Affiliated Institutions." Hospital pharmacy vol. 54,6 (2019): 365-370. doi: https://doi.org/10.1177/0018578718802831
Richards J, Wascher M, Alwan M, Beardsley J, Naseman R, Nesbit T, Trujillo T, Fuller P. State of Privileging in Pharmacy: A Survey of Vizient-Affiliated Institutions. Hosp Pharm. 2019 Dec;54(6):365-370. doi: 10.1177/0018578718802831. Epub 2018 Sep 22. PMID: 31762483; PMCID: PMC6852032.
Copy Download .nbib Format: NLM
The Knee Dislocation Classification System Is Simple, Reproducible, and Allows Communication among Surgeons.

The journal of knee surgery

Wascher DC, Schenck RC, Treme GP, Richter DL.
PMID: 33184799
J Knee Surg. 2020 Nov 12; doi: 10.1055/s-0040-1721036. Epub 2020 Nov 12.

No abstract available.

Cite
Wascher DC, Schenck RC, Treme GP, et al. The Knee Dislocation Classification System Is Simple, Reproducible, and Allows Communication among Surgeons. J Knee Surg. 2020;doi: 10.1055/s-0040-1721036.
Wascher, D. C., Schenck, R. C., Treme, G. P., & Richter, D. L. (2020). The Knee Dislocation Classification System Is Simple, Reproducible, and Allows Communication among Surgeons. The journal of knee surgery, . https://doi.org/10.1055/s-0040-1721036
Wascher, Daniel C, et al. "The Knee Dislocation Classification System Is Simple, Reproducible, and Allows Communication among Surgeons." The journal of knee surgery vol. (2020). doi: https://doi.org/10.1055/s-0040-1721036
Wascher DC, Schenck RC, Treme GP, Richter DL. The Knee Dislocation Classification System Is Simple, Reproducible, and Allows Communication among Surgeons. J Knee Surg. 2020 Nov 12; doi: 10.1055/s-0040-1721036. Epub 2020 Nov 12. PMID: 33184799.
Copy Download .nbib Format: NLM
Impact of Definitive Local Therapy in Men with Primary Small Cell Prostate Carcinoma.

European urology

Oke O, Ranasinghe W, Tang C, Shaaban S, Xiao L, Reichard CA, Anscher MS, Chapin BF, Aparicio A.
PMID: 33824032
Eur Urol. 2021 Sep;80(3):389-390. doi: 10.1016/j.eururo.2021.03.022. Epub 2021 Apr 03.

No abstract available.

Cite
Oke O, Ranasinghe W, Tang C, et al. Impact of Definitive Local Therapy in Men with Primary Small Cell Prostate Carcinoma. Eur Urol. 2021;80(3):389-390doi: 10.1016/j.eururo.2021.03.022.
Oke, O., Ranasinghe, W., Tang, C., Shaaban, S., Xiao, L., Reichard, C. A., Anscher, M. S., Chapin, B. F., & Aparicio, A. (2021). Impact of Definitive Local Therapy in Men with Primary Small Cell Prostate Carcinoma. European urology, 80(3), 389-390. https://doi.org/10.1016/j.eururo.2021.03.022
Oke, Oluchi, et al. "Impact of Definitive Local Therapy in Men with Primary Small Cell Prostate Carcinoma." European urology vol. 80,3 (2021): 389-390. doi: https://doi.org/10.1016/j.eururo.2021.03.022
Oke O, Ranasinghe W, Tang C, Shaaban S, Xiao L, Reichard CA, Anscher MS, Chapin BF, Aparicio A. Impact of Definitive Local Therapy in Men with Primary Small Cell Prostate Carcinoma. Eur Urol. 2021 Sep;80(3):389-390. doi: 10.1016/j.eururo.2021.03.022. Epub 2021 Apr 03. PMID: 33824032.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 45 entries